Remove unsupported claims about the schedule being distinct from CDC's recommendations.
Background
Maternal immunization is crucial for protecting both mothers and infants from vaccine-preventable diseases, which can lead to severe health outcomes. The updated ACOG schedule aims to provide clear guidance for healthcare providers in the U.S. regarding vaccination during pregnancy. The differences from CDC guidelines highlight the evolving nature of vaccine recommendations in obstetric care.
Data Highlights
No numerical data provided in the source material.
Key Findings
ACOG recommends four routine maternal vaccines: influenza, COVID-19, Tdap, and RSV.
Influenza and COVID-19 vaccines can be administered at any gestational age.
Tdap vaccination is advised during each pregnancy at 27-36 weeks of gestation.
Pfizer’s Abrysvo is the only recommended RSV vaccine for maternal vaccination.
Specific vaccines are suggested based on individual comorbidities or risk factors.
HPV vaccination should be initiated postpartum or while breastfeeding, not during pregnancy.
Clinical Implications
Healthcare providers should utilize the ACOG maternal immunization schedule to discuss vaccination with their patients. The schedule serves as a tool to enhance patient education on the importance of immunizations during pregnancy.
Conclusion
The 2026 maternal immunization schedule by ACOG provides essential guidance for obstetric care, emphasizing the importance of vaccination for maternal and infant health.
In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.
